Kemp EH, Waterman EA, Gawkrodger DJ, et al. Molecular mapping of epitopes on melanocyte-specific protein Pmell7 which are recognized by autoantibodies in patients with vitiligo. Clin Exp Immunol 2001; 124: 509–515.

Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J Invest Dermatol Symp Proc 2003; 8: 168–172.

Kunisada T, Yoshida H, Yamazaki H, et al. Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. Development 1998; 125: 2915–2923.

Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro, in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci 1982; 79: 2018–2022.

Situ R, Inman DR, Fligiel SEG, et al. Effects of alltrans-retinoic acid on melanocyte adhesion and motility. Dermatol 1993; 186: 38–44.

Takano N, Kawakami T, Kawa Y. et al. Fibronectin combined with stem cell factor plays an important role in melanocyte proliferation, differentiation and migration in cultured mouse neural crest cells. Pigment Cell Res 2002; 15: 192–200.

Neitmann M, Alexander M, Brinckmann J, et al. Attachment and chemotaxis of melanocytes after ultraviolet irradiation in vitro. Br J Dermatol 1999; 141: 794–801.

Sutton R, Gordon TC, Cree IA, et al. Tyr-TGFalpha transgenic mice develop ocular melanocytic lesions. Melanoma Res 2002; 12: 435–439.

Skurkovich SV, Skurkovich B, Kelly JA. Anticytokine therapy-new approach to the treatment of autoimmune and cytokine-disturbance diseases. Med Hypotheses 2002; 59: 770–780.

Carlie G, Ntusi NB, Hulley PA. et al. KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. Br J Dermatol 2003; 149: 707–717.

Roelandts R. Photo(chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed 2003; 19:1–4.